Table 2

Baseline characteristics of retrospective cohort of operated chronic subdural haematoma (n=530)

All (n=530)Referred (n=491)Local (n=39)P value
VariableMedian (IQR)
Age, years77 (69–84)77 (70–84)74 (62–79)0.010*
Creatinine, μmol/L73 (61–89)73 (61–89)76 (64–100)0.350
Time to surgery (within centre), hours20.1 (9.5–40.3)20.1 (9.8–42.7)19.7 (5.2–35.9)0.363
n (%)
Male376 (70.8)349 (70.9)27 (69.2)0.855
ASA ≥3271 (61.0)%250 (61.2)20 (57.1)0.718
Cognitively impaired270 (54.5)%254 (54.9)16 (48.5)0.485
Admission GCS 15342 (64.4)317 (64.5)25 (64.1)1
Admission Motor Score 6490 (92.3)459 (93.5)31 (79.5)0.001*
mRS ≥2105 (31.0)%104 (21.2)1 (20.0)1
Anticoagulants/antiplatelets232 (43.9)211 (43.0)21 (53.8)0.241
CVS disease238 (45.0)225 (45.8)13 (33.3)0.136
Heart failure101 (19.0)90 (18.3)11 (28.2)0.139
Airways disease75 (14.1)66 (13.4)9 (23.1)0.099
  • ‘Referred’ indicates cases referred from a regional hospital for surgery. ‘Local’ indicates a case admitted directly to the tertiary centre. Motor Score refers to score on the motor (movement) component of the Glasgow Coma Scale.

  • ASA of 3 or more indicates presence of significant systemic comorbidity, Modified Rankin Scale of 2 or more indicates a level of disability that impedes normal activity. % Indicates that value is calculated only on those with recorded values. P value calculated for Mann-Whitney U (continuous data) or Fisher’s exact test (categorical).

  • *Indicates significant at 5% level.

  • ASA, American Society of Anesthesiologists Score; CVS, cardiovascular; GCS, Glasgow Coma Scale; mRS, Modified Rankin Score.